Advertisement

Vitiligo pp 3-10 | Cite as

Historical Aspects of Vitiligo

  • Yvon Gauthier
  • Laila Benzekri
Chapter

Abstract

Vitiligo was recognized long ago under different names. Firstly, the Ebers Papyrus (circa 1500 BC) mentions two types of diseases affecting the colour of the skin, one being probably leprosy and the other vitiligo. In the ancient Vedic scripture of India (circa 1400 BC), Sanskrit words “kilas” and “svitra” (white patches on the skin) can be found. The early classics of the Far East (1200 BC) mention “shirabito” (white man). The Hebrew word “Zoorat” in the bible corresponds to a group of achromic diseases including vitiligo. “Baras and alabras” were the Arabic names used to describe vitiligo. The term “vitiligo” itself was introduced in the first century of our era. The confusion of leprosy with vitiligo in the Old Testament under “Zoorat” is an important cause for the social stigma attached to white spots on the skin. Detailed and effective treatments for vitiligo are found in different sacred books. The modern photochemotherapy is an improvement of a photochemotherapy practised in the ancient world with herbals containing furocoumarins (mainly Ammi majus Linnaeus, Psoralea corylifolia) and sun. In the mid-1960s the synthetic furocoumarin (trioxsalen and trimethylpsoralen) were developed. The effectiveness of PUVA (psoralen + UVA) for the treatment of some patients with vitiligo was confirmed during 1974–1982. More recently, narrowband UVB therapy, local microphototherapy, excimer laser, topical treatments with corticosteroids and calcineurin inhibitors and melanocyte transplantation have been successively introduced.

References

  1. 1.
    Goldman L, Richard S, Moraites R. White spots in Biblical Times. Arch Dermatol. 1966;93:744–53.CrossRefGoogle Scholar
  2. 2.
    Ortonne JP, Mosher DP, Fitzpatrick TB. Vitiligo and other hypomelanoses of hair and skin. New York, NY: Plenum medical school; 1983. p. 129–32.CrossRefGoogle Scholar
  3. 3.
    Ebbel B. The papyrus Ebers. Copenhagen: Levin and Munksgaard; 1963.Google Scholar
  4. 4.
    Donata SR, Kesavan M, Austin SR. Clinical trial of certain Ayurveda medicines indicated in vitiligo. Ancient Sci Life. 1990;4:202–6.Google Scholar
  5. 5.
    Nair BK. Vitiligo: a retrospect. Int J Dermatol. 1978;17:755–7.CrossRefGoogle Scholar
  6. 6.
    Panda AK. The medicohistorical perspective of vitiligo. Bull Ind Hist Med. 2005;25:41–6.Google Scholar
  7. 7.
    Ben Achour T. TafsirAt Tahir Wat-Tanwir. Edn Dar SahouneHannadi, city, 1973.Google Scholar
  8. 8.
    Olsson M, Juhlin M. Leucoderma treated by transplantation of a basal cell layer enriched suspension. Br J Dermatol. 1998;138:644–8.CrossRefGoogle Scholar
  9. 9.
    Prasad PV, Bhatnagar VK. Medico-historical study of “Kilasa” (vitiligo/leucoderma) a common skin disorder. Bull Ind Inst Hist Med. 2003;33:113–27.Google Scholar
  10. 10.
    Harris JL, Lerner AB. Amino acid sequence of alpha-melanocyte stimulating hormone. Nature. 1957;179:1346–7.CrossRefGoogle Scholar
  11. 11.
    Fahmy IR, Abn-Shady H. Pharmacological study and isolation of crystalline constituents: Amoïdin. Quart J Pharm and Pharmacol. 1947;20:281–6.Google Scholar
  12. 12.
    Pathak M, Daniels F, Fitzpatrick TB. The presently known distribution of furocoumarins (psoralens) in plants. J Invest Dermatol. 1962;39:225–39.CrossRefGoogle Scholar
  13. 13.
    Kuske H. Experimentelle untershungersur Photosensibiliste der Haut durch pflanzliche Wisrktoffe. Arch F Dermatol et Syphil. 1938;178:112–4.CrossRefGoogle Scholar
  14. 14.
    El Mofty AM. A preliminary clinical report on the treatment of leukodermias with Ammi Majus Linn. J Roy Egypt. 1948;31:651–6.Google Scholar
  15. 15.
    Lerner AB, McGuire JS. Vitiligo and sympathectomy: the effect of sympathectomy and alpha-melanocyte stimulating hormone. Arch Dermatol. 1966;94:269–78.CrossRefGoogle Scholar
  16. 16.
    Lim HW, Grimes PE, Agbai O, et al. Afamelanotide and narrowband UVB phototherapy for the treatment of vitiligo: a randomized multicenter trial. JAMA Dermatol. 2015;151(1):42–50.CrossRefGoogle Scholar
  17. 17.
    Pathak M, Fitzpatrick TB. The evolution of photochemotherapy with psoralens and UVA (PUVA) 2000BC to 1992 AD. J Photochem Photobiol. 1992;14:3–22.CrossRefGoogle Scholar
  18. 18.
    Lotti TM, Menchini G, Andreassi L. UV-B radiation microphototherapy. An elective treatment for segmental vitiligo. J Eur Acad Dermatol Venereol. 1999;12:102–8.CrossRefGoogle Scholar
  19. 19.
    Behl PN. Treatment of vitiligo with homologous thin Thiersch skin grafts. Curr Med Pract. 1964;8:218–21.Google Scholar
  20. 20.
    Falabella R. Epidermal grafting: an original technique and its application in achromic areas. Arch Dermatol. 1971;104:592–600.CrossRefGoogle Scholar
  21. 21.
    Falabella R. Repigmentation of leucoderma by autologous epidermal grafting. J Dermatol Surg Oncol. 1984;10:136–44.CrossRefGoogle Scholar
  22. 22.
    Falabella R, Escobar C, Borrero L. Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes. J Am Acad Dermatol. 1992;262(1):230–6.CrossRefGoogle Scholar
  23. 23.
    Gauthier Y, Surleve-Bazeille JE. Autologous grafting with non cultured melanocytes: a simplified method for treatment of depigmented lesions. J Am Acad Dermatol. 1992;26:191–4.CrossRefGoogle Scholar
  24. 24.
    Olsson M, Juhlin M. Melanocyte transplantation in vitiligo. Lancet. 1992;34(8825):981.CrossRefGoogle Scholar
  25. 25.
    Mac Neil S, Eves P. Simplifying the delivery of cultured melanocytes. In: Gupta S, Olsson MJ, Kanwar A, editors. Surgical management of vitiligo. Oxford: Blackwell; 2007. p. 191–201.Google Scholar
  26. 26.
    Singh C, Parsad D, Kanwar AJ, Dogras AS, Kumar R. Comparison between autologous non cultured extracted hair follicle outer root sheath cell suspension and autologous non cultured epidermal cell suspension in the treatment of stable vitiligo: a randomized study. Br J Dermatol. 2013;169(2):287–93.CrossRefGoogle Scholar
  27. 27.
    Vanscheidt W, Hunziker T. Repigmentation by outer-root sheath-derived melanocytes: proof of concept in vitiligo and leucoderma. Dermatology. 2009;218(4):342–3.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Yvon Gauthier
    • 1
  • Laila Benzekri
    • 2
  1. 1.Former Consultant, Department of DermatologyCHU de BordeauxBordeauxFrance
  2. 2.Department of Dermatology, CHU Ibn SinaMohammed V UniversityRabatMorocco

Personalised recommendations